Close Menu

HIV

NEW YORK (GenomeWeb) — ATCC has partnered with the US Centers for Disease Control and Prevention and Thermo Fisher Scientific to bring a rapid, cost-effective PCR-based method of monitoring HIV drug resistance to resource-limited countries, ATCC said today.

NEW YORK (GenomeWeb) – Advanced Biological Laboratories and the HIV Resistance Response Database Initiative (RDI) this week announced a collaboration on HIV management.

NEW YORK (GenomeWeb) – Sangamo BioSciences today said that the California Institute for Regenerative Medicine has awarded $5.6 million grant to researchers at City of Hope to develop an HIV/AIDS therapeutic based on Sangamo's zinc finger nuclease genome editing technology.

NEW YORK (GenomeWeb) — Beckman Coulter Diagnostics said this month that it has received CE marking for Veris MDx, its "sample-in, results-out" real-time PCR-based molecular diagnostics system, as well as the platform's first assay, a quantitative viral load test for human cytomegalovirus.

NEW YORK (GenomeWeb) – Diaxonhit today said that Bpifrance has granted it more than €1.7 million ($2.4 million) to develop a companion diagnostic for an AIDS vaccine under development.

NEW YORK (GenomeWeb) – Rheonix today said it received a Small Business Innovation Research Phase I Fast-Track grant to complete the development of its fully automated self-confirming assay for the simultaneous detection of HIV/AIDS antibodies and viral RNA in a single specimen.

NEW YORK (GenomeWeb News) — Grifols said today that it has been selected by the Japanese Red Cross Society as a partner in nucleic acid screening of the country's 5.3 million annual blood donations.

ALBUQUERQUE, NM (GenomeWeb News) — Long-read sequencing can enable researchers to not only detect what drug-resistance mutations are present in someone with HIV, but also whether those mutations are present in one strain or spread across multiple strains of the virus circulating in that patient,

In BMC Genomics, Swiss researchers described efforts to sequence and characterize the genome of a previously unknown Gram-negative bacterial species from a family called Alcal

The National Institutes of Health this month awarded roughly $1.4 million in grant money to researchers at the University of Texas and Tekmira Pharmaceuticals to support their development of a single RNAi-based drug that can treat both Ebola virus and Marburg virus infections.

Pages

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.